P00974 (BPT1_BOVIN) Bos taurus (Bovine)
Pancreatic trypsin inhibitor UniProtKBInterProSTRINGInteractive Modelling
100 aa; Sequence (Fasta) ;
1 identical sequence: Bos indicus x Bos taurus: A0A4W2HUW2
It is possible new templates exist for this target since these models were created.
Available Structures
126 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
CRYSTAL STRUCTURE OF THE P1 MET BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
Heteromer P00766; | 7×SO4; | ||||
Assess | ||||||
Extremely stable complex of crayfish trypsin with bovine trypsin inhibitor |
Heteromer Q52V24; | 2×CA; 1×SO4; | ||||
Assess | ||||||
Trypsin in complex with with BPTI |
Heteromer P00760; | 9×SO4; 2×GOL; 1×CA; | ||||
Assess | ||||||
Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor variant (BPTI-K15R/R17D) |
Heteromer P35030; | 1×CA; | ||||
Assess | ||||||
Human mesotrypsin-S39Y complexed with bovine pancreatic trypsin inhibitor (BPTI) |
Heteromer P35030; | 5×SO4; 1×CA; | ||||
Assess | ||||||
Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(BPTI) |
Heteromer P35030; | 8×SO4; | ||||
Assess | ||||||
Anionic trypsin variant S195A in complex with bovine pancreatic trypsin inhibitor (BPTI) cleaved at… |
Heteromer P00763; | 5×EDO; 1×PG4; 1×CA; 4×SO4; | ||||
Assess | ||||||
Anionic trypsin variant S195A in complex with bovine pancreatic trypsin inhibitor (BPTI) determined… |
Heteromer P00763; | 6×EDO; 1×PG4; 1×CA; 4×SO4; | ||||
Assess | ||||||
Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI) |
Heteromer P07477; | 2×CA; 24×SO4; | ||||
Assess | ||||||
Anionic trypsin in complex with bovine pancreatic trypsin inhibitor (BPTI) determined to the 1.49 A… |
Heteromer P00763; | 8×EDO; 1×PG4; 1×CA; 4×SO4; | ||||
Assess | ||||||
Crystal structure of a BPTI variant (Cys14->Ser, Cys38->Ser) in complex with trypsin |
Heteromer P00760; | 1×NA; 2×CA; 8×SO4; 6×EDO; | ||||
Assess | ||||||
Crystal structure of a BPTI variant (Cys14->Ser) in complex with trypsin |
Heteromer P00760; | 1×NA; 2×CA; 8×SO4; 6×EDO; | ||||
Assess | ||||||
Crystal structure of a BPTI variant (Cys38->Ser) in complex with trypsin |
Heteromer P00760; | 1×NA; 2×CA; 8×SO4; 7×EDO; | ||||
Assess | ||||||
Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor variant (BPTI-K15R/R17G) |
Heteromer P35030; | 1×CA; | ||||
Assess | ||||||
A Crystal Structure of Trypsin Complexed with BPTI (Bovine Pancreatic Trypsin Inhibitor) by X-ray/N… |
Heteromer P00760; | 1×CA; 5×SO4; | ||||
Assess | ||||||
Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket o… |
Heteromer P00760; | 1×CA; 2×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF TICK ANTICOAGULANT PROTEIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR |
Heteromer P17726; | 3×SO4; | ||||
Assess | ||||||
Crystal structure of trypsin complexed with BPTI at 100K |
Heteromer P00760; | 1×NA; 2×CA; 8×SO4; 6×EDO; | ||||
Assess | ||||||
Crystal structure of trypsin complexed with the BPTI variant (Tyr35->Gly) |
Heteromer P00760; | 1×NA; 9×SO4; 2×CA; 4×EDO; | ||||
Assess | ||||||
Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket o… |
Heteromer P00760; | 1×CA; 2×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE P1 TRP BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
Heteromer P00766; | 7×SO4; | ||||
Assess | ||||||
human cationic trypsin G193R mutant in complex with bovine pancreatic trypsin inhibitor |
Heteromer P07477; | 5×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE P1 THR BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
Heteromer P00766; | 6×SO4; | ||||
Assess | ||||||
Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket o… |
Heteromer P00766; | 5×SO4; | ||||
Assess | ||||||
Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket o… |
Heteromer P00766; | 7×SO4; 1×TRS; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE P1 HIS BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
Heteromer P00766; | 7×SO4; | ||||
Assess | ||||||
Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket o… |
Heteromer P00766; | 5×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE P1 difluoroethylglycine (DfeGly) BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
Heteromer P00766; | 29×GOL; 15×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE P1 aminobutanoic acid (ABU) BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
Heteromer P00766; | 29×GOL; 15×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN |
Heteromer P00760; | 4×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE P1 GLU BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
Heteromer P00766; | 7×SO4; | ||||
Assess | ||||||
THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEX… |
Heteromer P00760; | 1×CA; 2×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE P1 monofluorethylglycine(MfeGly) BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
Heteromer P00766; | 28×GOL; 17×SO4; | ||||
Assess | ||||||
THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEX… |
Heteromer P00760; | 1×CA; | ||||
Assess | ||||||
THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEX… |
Heteromer P00760; | 1×CA; | ||||
Assess | ||||||
THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEX… |
Heteromer P00760; | 1×ILE; 1×VAL; 1×CA; 2×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE P1 trifluoroethylglycine (TfeGly) BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX |
Heteromer P00766; | 30×GOL; 20×SO4; | ||||
Assess | ||||||
Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket o… |
Heteromer P00766; | 5×SO4; | ||||
Assess | ||||||
THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR |
Heteromer P35031; | 1×CA; | ||||
Assess | ||||||
THE REFINED 2.2-ANGSTROMS (0.22-NM) X-RAY CRYSTAL STRUCTURE OF THE TERNARY COMPLEX FORMED BY BOVINE… |
Heteromer P00760; | 2×VAL; 1×CA; 2×SO4; | ||||
Assess | ||||||
STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR |
Heteromer P00734; | |||||
Assess | ||||||
BOVINE CHYMOTRYPSIN COMPLEXED TO BPTI |
Heteromer P00766; | |||||
Assess | ||||||
BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION |
Heteromer P00766; | 2×SO4; | ||||
Assess | ||||||
Trypsin in complex with BPTI mutant (2S)-2-amino-4-monofluorobutanoic acid |
Heteromer P00760; | 13×SO4; 9×GOL; 1×CA; | ||||
Assess | ||||||
Trypsin in complex with with BPTI mutant (2S)-2-amino-4,4,4-trifluorobutanoic acid |
Heteromer P00760; | 9×SO4; 2×GOL; 1×CA; | ||||
Assess | ||||||
Trypsin in complex with with BPTI mutant AMINOBUTYRIC ACID |
Heteromer P00760; | 10×SO4; 1×CA; 2×GOL; | ||||
Assess | ||||||
Trypsin in complex with with BPTI mutant (2S)-2-amino-4,4-difluorobutanoic acid |
Heteromer P00760; | 9×SO4; 1×GOL; 1×CA; | ||||
Assess | ||||||
RAT TRYPSINOGEN MUTANT COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR |
Heteromer P00763; | 1×CA; | ||||
Assess | ||||||
ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALL… |
Heteromer P00760; | 1×ILE; 1×VAL; 1×HG; | ||||
Assess | ||||||
REFINED 2.5 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF THE COMPLEX FORMED BY PORCINE KALLIKREIN A AND THE… |
Heteromer P00752; | |||||
Assess | ||||||
Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket o… |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
RAT TRYPSINOGEN K15A COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR |
Heteromer P00763; | 1×CA; 2×SO4; | ||||
Assess | ||||||
TRYPSINOGEN MUTANT D194N AND DELETION OF ILE 16-VAL 17 COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INH… |
Heteromer P00763; | 1×CA; 3×SO4; | ||||
Assess | ||||||
Trypsin/Bpti complex mutant |
Heteromer P00763; | 1×CA; 2×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE DELTAILE16VAL17 RAT ANIONIC TRYPSINOGEN-BPTI COMPLEX |
Heteromer P00763; | 1×CA; 3×SO4; | ||||
Assess | ||||||
Trypsin/BPTI complex mutant |
Heteromer P00763; | 1×CA; 2×SO4; | ||||
Assess | ||||||
Trypsin/BPTI complex mutant |
Heteromer P00763; | 1×CA; 2×SO4; | ||||
Assess | ||||||
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
WILD-TYPE RAT ANIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) |
Heteromer P00763; | 1×CA; 2×SO4; | ||||
Assess | ||||||
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI. |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
Aprotinin bound to Dengue virus protease |
Heteromer Q5UB51; | |||||
Assess | ||||||
The Crystal Structures of the Complexes Between Bovine Beta-Trypsin and Ten P1 Variants of BPTI. |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
The Crystal Structures of the Complexes Between the Bovine Beta-Trypsin and Ten P1 Variants of BPTI. |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI |
Heteromer P00760; | 1×CA; 4×SO4; | ||||
Assess | ||||||
S195A TRYPSINOGEN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) |
Heteromer P00763; | 1×CA; 2×SO4; | ||||
Assess | ||||||
Crystal Structure of the West Nile virus NS2B-NS3 protease complexed with bovine pancreatic trypsin… |
Heteromer P06935; | |||||
Assess | ||||||
Crystal structure of the MTSP1 (matriptase)-BPTI (aprotinin) complex |
Heteromer Q9Y5Y6; | |||||
Assess | ||||||
Human cationic trypsin K97D mutant in complex with bovine pancreatic trypsin inhibitor (BPTI) |
Heteromer P07477; | 1×CA; 2×SO4; | ||||
Assess | ||||||
Crystal structures of unlinked full length NS3 from Dengue virus provide insights into dynamics of … |
Heteromer F8TEL4; | 1×GOL; | ||||
Assess | ||||||
Crystal structure of full length NS3 protein (eD4NS2BNS3) in complex with Bovine Pancreatic Trypsin… |
Heteromer F8TEL4; W0LLP9; | |||||
Assess | ||||||
HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT |
Heteromer P08709; P13726; | 1×GLC; 1×FUC; 2×CA; | ||||
Assess | ||||||
Structure of Prostasin in Complex with Aprotinin |
Heteromer Q16651; | |||||
Assess | ||||||
CRYSTAL STRUCTURES OF RAT ANIONIC TRYPSIN COMPLEXED WITH THE PROTEIN INHIBITORS APPI AND BPTI |
Heteromer P00763; | |||||
Assess | ||||||
R117H mutant rat anionic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI) |
Heteromer P00763; | 1×CA; | ||||
Assess | ||||||
Solution structure of BetaCore, A Designed Water Soluble Four-Stranded Antiparallel b-sheet Protein |
Heteromer | 1×C55; | ||||
Assess | ||||||
Crystal structure of aprotinin in complex with sucrose octasulfate: unusual interactions and implic… | homo-10-mer | 36×SO4; 10×HG; 4×GOL; | ||||
Assess | ||||||
EVIDENCE OF A COMMON DECAMER IN THREE CRYSTAL STRUCTURES OF BPTI, CRYSTALLIZE FROM THIOCYANATE, CHL… | homo-10-mer | 6×SO4; | ||||
Assess | ||||||
Crystal structure of aprotinin in complex with sucrose octasulfate: unusual interactions and implic… | homo-10-mer | |||||
Assess | ||||||
BOVINE PANCREATIC TRYPSIN INHIBITOR CRYSTALLIZED FROM THIOCYANATE | homo-10-mer | 10×SCN; | ||||
Assess | ||||||
EVIDENCE OF A COMMON DECAMER IN THREE CRYSTAL STRUCTURES OF BPTI, CRYSTALLIZED FROM THIOCYANATE, CH… | homo-10-mer | |||||
Assess | ||||||
DECAMERS OBSERVED IN THE CRYSTALS OF BOVINE PANCREATIC TRYPSIN INHIBITOR | homo-5-mer | 8×SO4; | ||||
Assess | ||||||
Structure of a BPTI-[5,55] variant containing Gly/Val at the 14/38th positions | homo-2-mer | 3×SO4; | ||||
Assess | ||||||
Bovine pancreatic trypsin inhibitor (BPTI) containing only the [5,55] disulfide bond | homo-2-mer | 4×SO4; | ||||
Assess | ||||||
ULTRA HIGH RESOLUTION STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT WITH ALTERED B… | monomer | 8×SO4; 2×EDO; | ||||
Assess | ||||||
Crystal Structure of Cyclic Bovine Pancreatic Trypsin Inhibitor | monomer | 7×SO4; 2×EDO; | ||||
Assess | ||||||
THE STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR AT 125K: DEFINITION OF CARBOXYL-TERMINAL RESID… | monomer | 1×PO4; | ||||
Assess | ||||||
A BPTI-[5,55] variant with C14GA38L mutations | monomer | 4×SO4; | ||||
Assess | ||||||
A BPTI-[5,55] variant with C14GA38G mutations | monomer | 3×SO4; | ||||
Assess | ||||||
BASIC PANCREATIC TRYPSIN INHIBITOR (MET 52 OXIDIZED) | monomer | 1×PO4; | ||||
Assess | ||||||
Hetero-micro-seeding: Crystal structure of BPTI-[555]C14GA38I variant using micro-seeds from -C14GA… | monomer | 1×SO4; | ||||
Assess | ||||||
Hetero-micro-seeding: Crystal structure of BPTI-[5,55]C14GA38I variant using micro-seeds from -C14G… | monomer | 1×SO4; | ||||
Assess | ||||||
Hetero-micro-seeding: Crystal structure of BPTI-[5,55]C14GA38I variant using micro-seeds from -C14G… | monomer | 2×SO4; | ||||
Assess | ||||||
A BPTI-[5,55] variant with C14GA38I mutations | monomer | 2×SO4; | ||||
Assess | ||||||
Bovine Pancreatic Trypsin Inhibitor (BPTI) Mutant with Altered Binding Loop Sequence | monomer | 4×SO4; | ||||
Assess | ||||||
THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEX… | monomer | |||||
Assess | ||||||
STRUCTURAL EFFECTS INDUCED BY MUTAGENESIS AFFECTED BY CRYSTAL PACKING FACTORS: THE STRUCTURE OF A 3… | monomer | |||||
Assess | ||||||
STRUCTURAL EFFECTS INDUCED BY REMOVAL OF A DISULFIDE BRIDGE. THE X-RAY STRUCTURE OF THE C30A(SLASH)… | monomer | 1×PO4; | ||||
Assess | ||||||
A BPTI-[5,55] variant with C14GA38K mutations | monomer | 3×SO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF A Y35G MUTANT OF BOVINE PANCREATIC TRYPSIN INHIBITOR | monomer | |||||
Assess | ||||||
A simplified BPTI variant containing 21 alanines out 58 of residues | monomer | 1×SO4; | ||||
Assess | ||||||
CREVICE-FORMING MUTANTS IN THE RIGID CORE OF BOVINE PANCREATIC TRYPSIN INHIBITOR: CRYSTAL STRUCTURE… | monomer | |||||
Assess | ||||||
CREVICE-FORMING MUTANTS IN THE RIGID CORE OF BOVINE PANCREATIC TRYPSIN INHIBITOR: CRYSTAL STRUCTURE… | monomer | |||||
Assess | ||||||
DETERMINATION OF A HIGH-QUALITY NUCLEAR MAGNETIC RESONANCE SOLUTION STRUCTURE OF THE BOVINE PANCREA… | monomer | |||||
Assess | ||||||
STRUCTURE OF BPTI MUTANT A16V | monomer | |||||
Assess | ||||||
The solution structure of bovine pancreatic trypsin inhibitor at high pressure | monomer | |||||
Assess | ||||||
STRUCTURE OF BPTI_8A MUTANT | monomer | |||||
Assess | ||||||
The solution structure of bovine pancreatic trypsin inhibitor at high pressure | monomer | |||||
Assess | ||||||
NMR Structure of BPTI Mutant G37A | monomer | |||||
Assess | ||||||
NMR Structure of BPTI Mutant G37A | monomer | |||||
Assess | ||||||
STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR. RESULTS OF JOINT NEUTRON AND X-RAY REFINEMENT OF … | monomer | 1×PO4; 1×UNX; | ||||
Assess | ||||||
A simplified BPTI variant containing 22 alanines out of 58 residues | monomer | 1×SO4; | ||||
Assess | ||||||
STRUCTURE OF FORM III CRYSTALS OF BOVINE PANCREATIC TRYPSIN INHIBITOR | monomer | 1×PO4; | ||||
Assess | ||||||
The methylene thioacetal BPTI (Bovine Pancreatic Trypsin Inhibitor) mutant structure | monomer | 5×SO4; 1×GOL; | ||||
Assess | ||||||
A simplified BPTI variant containing 23 alanines out of 58 residues | monomer | 1×SO4; | ||||
Assess | ||||||
A simplified BPTI variant with poly Lys amino acid tag (C3K) at the C-terminus | monomer | |||||
Assess | ||||||
Crystal structure of aprotinin in complex with sucrose octasulfate: unusual interactions and implic… | monomer | |||||
Assess | ||||||
A simplified BPTI variant containing 24 alanines out of 58 residues | monomer | 2×SO4; | ||||
Assess | ||||||
CREVICE-FORMING MUTANTS IN THE RIGID CORE OF BOVINE PANCREATIC TRYPSIN INHIBITOR: CRYSTAL STRUCTURE… | monomer | 1×PO4; | ||||
Assess | ||||||
CREVICE-FORMING MUTANTS OF BPTI: CRYSTAL STRUCTURES OF F22A, Y23A, N43G, AND F45A | monomer | 1×PO4; | ||||
Assess | ||||||
Solution structure of a truncated bovine pancreatic trypsin inhibitor, 3-58 BPTI. | monomer | |||||
Assess | ||||||
Solution structure of a truncated bovine pancreatic trypsin inhibitor mutant, 3-58 BPTI (K15R, R17A… | monomer | |||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
4bnr.1.B | monomer | 0.76 | 100.00 | |||
Assess |